“Efficacy and Safety of CD19-Targeted Chimeric Antigen Receptor (CAR) T-Cell Therapy in Refractory Systemic Lupus Erythematosus: A Systematic Review of Clinical Outcomes and B-Cell Depletion Kinetics” (2025) Archives of The Medicine and Case Reports, 7(1), pp. 1–18. doi:10.37275/amcr.v7i1.831.